For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Denali Therapeutics Inc (NASDAQ: DNLI) was $14.95 for the day, down -10.43% from the previous closing price of $16.69. In other words, the price has decreased by -$10.43 from its previous closing price. On the day, 1.74 million shares were traded.
Ratios:
Our analysis of DNLI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.46 and its Current Ratio is at 8.46. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $31.
On January 07, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $31.Robert W. Baird initiated its Outperform rating on January 07, 2025, with a $31 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’25 when Ho Carole sold 12,255 shares for $20.22 per share. The transaction valued at 247,796 led to the insider holds 178,580 shares of the business.
Ho Carole sold 2,907 shares of DNLI for $60,495 on Jan 07 ’25. The Chief Medical Officer now owns 175,673 shares after completing the transaction at $20.81 per share. On Jan 06 ’25, another insider, Schuth Alexander O., who serves as the COFO and Secretary of the company, sold 12,255 shares for $20.22 each. As a result, the insider received 247,796 and left with 247,215 shares of the company.
Stock Price History:
Over the past 52 weeks, DNLI has reached a high of $33.33, while it has fallen to a 52-week low of $14.01. The 50-Day Moving Average of the stock is -27.64%, while the 200-Day Moving Average is calculated to be -36.62%.
Shares Statistics:
A total of 142.63M shares are outstanding, with a floating share count of 125.71M. Insiders hold about 13.43% of the company’s shares, while institutions hold 88.05% stake in the company.
